ConductScience.org, home

Comparison · NCT02284191-33a08f35

CT Coronary Angiogram vs Standard Care: Subsequent Non-fatal MI (Type 1 or 4b)

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. CT Coronary Angiogram vs Standard Care: Subsequent Non-fatal MI (Type 1 or 4b). Trial comparisons, record NCT02284191-33a08f35. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02284191-33a08f35

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.03990.02880.055wilson
Risk in group 20.04360.03190.0593wilson
Risk difference, group 1 minus group 2-0.00372-0.02290.0154newcombe hybrid score
Risk ratio, group 1 over group 20.9150.5841.43log
Odds ratio, group 1 over group 20.9110.571.46log
Number needed to treat, for one fewer participant with the outcome on CT Coronary Angiogram than on Standard Care269from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: standard care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1CT Coronary AngiogramCT Coronary Angiogram plus standard care~CT Coronary Angiogram: Completion of a CT Coronary Angiogram35877OG000
Group 2Standard CareStandard care only38871OG001

Outcome

Type
SECONDARY
Title
Subsequent Non-fatal MI (Type 1 or 4b)
Description
Number of participants with subsequent non-fatal myocardial infarction (type 1 or 4b), one year post randomisation
Time frame
1 year (post-randomisation)
Population

Source ClinicalTrials.gov

Trial

Title
Rapid Assessment of Potential Ischaemic Heart Disease With CTCA
NCT number
NCT02284191
Phases
NA
Conditions
Acute Coronary Syndrome
Interventions
CT Coronary Angiogram
Lead sponsor
University of Edinburgh
Results first posted
2024-08-21

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02284191-33a08f35